College of Law’s building design recognized with citation of merit
AIA Chicago, the second largest local chapter of the American Institute of Architects, recently recognized the University of Cincinnati College of Law building design with a citation of merit within the Interior Architecture Large category of the 2023 Design Excellence Awards. BHDP served as Architect of Record and Perkins & Will served as the Design Architect.
The $45.6M renovation and expansion of the former Lindner College of Business has created a six-story building that offers amenities such as collaborative study areas, shared classrooms, grand lecture halls, and mock courtrooms, to support students, faculty, and staff.
Read more about the award: AIA Chicago Announces Winners of the 2023 Design Excellence Awards, Decarbonization Award, Roberta Feldman Architecture for Social Justice Award and the Lerch Bates People’s Choice Awards
Read more about the project from the Architect of Record: BHDP
Lead photo taken by Perkins + Will
Tags
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.